Loading…
Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors
Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets...
Saved in:
Published in: | Frontiers in cellular neuroscience 2020-07, Vol.14, p.174-174 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853 |
---|---|
cites | cdi_FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853 |
container_end_page | 174 |
container_issue | |
container_start_page | 174 |
container_title | Frontiers in cellular neuroscience |
container_volume | 14 |
creator | Sami, Armin Selzer, Michael E Li, Shuxin |
description | Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets for designing effective therapies for traumatic brain injury or spinal cord injury (SCI). CSPGs bind with high affinity to several transmembrane receptors, including two members of the leukocyte common antigen related (LAR) subfamily of receptor protein tyrosine phosphatases (RPTPs). Recent studies demonstrate that multiple intracellular signaling pathways downstream of these two RPTPs mediate the growth-inhibitory actions of CSPGs. A better understanding of these signaling pathways may facilitate development of new and effective therapies for CNS disorders characterized by axonal disconnections. This review will focus on recent advances in the downstream signaling pathways of scar-mediated inhibition and their potential as the molecular targets for CNS repair. |
doi_str_mv | 10.3389/fncel.2020.00174 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1994916447cf4d11b80f8de760e64977</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_1994916447cf4d11b80f8de760e64977</doaj_id><sourcerecordid>2419545042</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853</originalsourceid><addsrcrecordid>eNpdkU1vEzEQhlcIRD_gzglZ4sJlgz_G9vqCFLU0RKoEonC27LU362hjF3vT0H_PJilVy8kjzzuP7Hmq6h3BM8Ya9amLrR9mFFM8w5hIeFGdEiFozQmmL5_UJ9VZKWuMBRXQvK5OGJUECMen1Y-5uzMTpaAQ0dh7dBNW0QwhrtB3M_Y7c1_QZdrFMmZvNih1aDEEM9Q3rclo_idFtMhpN_ZoGftgw5hyeVO96sxQ_NuH87z6dfXl58XX-vrbYnkxv65bUHisiZVUcUYocGaFJ7a1nuIGJFBqHEw94R0IAdxZJ6FRHRXEGug4EMEazs6r5ZHrklnr2xw2Jt_rZII-XKS80iaPoR28JkqBIgJAth04QmyDu8Z5KbAXoKScWJ-PrNut3XjX-jhmMzyDPu_E0OtVutOSgZCCTYCPD4Ccfm99GfUmlEnOYKJP26IpUMkpa6Saoh_-i67TNk9L36eI4sAx0CmFj6k2p1Ky7x4fQ7Dey9cH-XovXx_kTyPvn37iceCfbfYXV3-pTw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2419545042</pqid></control><display><type>article</type><title>Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors</title><source>PubMed Central (Open Access)</source><source>Publicly Available Content (ProQuest)</source><creator>Sami, Armin ; Selzer, Michael E ; Li, Shuxin</creator><creatorcontrib>Sami, Armin ; Selzer, Michael E ; Li, Shuxin</creatorcontrib><description>Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets for designing effective therapies for traumatic brain injury or spinal cord injury (SCI). CSPGs bind with high affinity to several transmembrane receptors, including two members of the leukocyte common antigen related (LAR) subfamily of receptor protein tyrosine phosphatases (RPTPs). Recent studies demonstrate that multiple intracellular signaling pathways downstream of these two RPTPs mediate the growth-inhibitory actions of CSPGs. A better understanding of these signaling pathways may facilitate development of new and effective therapies for CNS disorders characterized by axonal disconnections. This review will focus on recent advances in the downstream signaling pathways of scar-mediated inhibition and their potential as the molecular targets for CNS repair.</description><identifier>ISSN: 1662-5102</identifier><identifier>EISSN: 1662-5102</identifier><identifier>DOI: 10.3389/fncel.2020.00174</identifier><identifier>PMID: 32714150</identifier><language>eng</language><publisher>Switzerland: Frontiers Research Foundation</publisher><subject>Antigens ; axon regeneration ; Cellular Neuroscience ; Chondroitin sulfate ; CSPG receptor ; Heparan sulfate ; Injuries ; intracellular signaling ; Intracellular signalling ; Kinases ; LAR ; Mammals ; Phosphatase ; Proteins ; Proteoglycans ; PTPσ ; Regeneration ; scar inhibition ; Signal transduction ; Spinal cord ; Spinal cord injuries ; Traumatic brain injury ; Tyrosine</subject><ispartof>Frontiers in cellular neuroscience, 2020-07, Vol.14, p.174-174</ispartof><rights>Copyright © 2020 Sami, Selzer and Li.</rights><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2020 Sami, Selzer and Li. 2020 Sami, Selzer and Li</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853</citedby><cites>FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2419545042/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2419545042?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32714150$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sami, Armin</creatorcontrib><creatorcontrib>Selzer, Michael E</creatorcontrib><creatorcontrib>Li, Shuxin</creatorcontrib><title>Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors</title><title>Frontiers in cellular neuroscience</title><addtitle>Front Cell Neurosci</addtitle><description>Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets for designing effective therapies for traumatic brain injury or spinal cord injury (SCI). CSPGs bind with high affinity to several transmembrane receptors, including two members of the leukocyte common antigen related (LAR) subfamily of receptor protein tyrosine phosphatases (RPTPs). Recent studies demonstrate that multiple intracellular signaling pathways downstream of these two RPTPs mediate the growth-inhibitory actions of CSPGs. A better understanding of these signaling pathways may facilitate development of new and effective therapies for CNS disorders characterized by axonal disconnections. This review will focus on recent advances in the downstream signaling pathways of scar-mediated inhibition and their potential as the molecular targets for CNS repair.</description><subject>Antigens</subject><subject>axon regeneration</subject><subject>Cellular Neuroscience</subject><subject>Chondroitin sulfate</subject><subject>CSPG receptor</subject><subject>Heparan sulfate</subject><subject>Injuries</subject><subject>intracellular signaling</subject><subject>Intracellular signalling</subject><subject>Kinases</subject><subject>LAR</subject><subject>Mammals</subject><subject>Phosphatase</subject><subject>Proteins</subject><subject>Proteoglycans</subject><subject>PTPσ</subject><subject>Regeneration</subject><subject>scar inhibition</subject><subject>Signal transduction</subject><subject>Spinal cord</subject><subject>Spinal cord injuries</subject><subject>Traumatic brain injury</subject><subject>Tyrosine</subject><issn>1662-5102</issn><issn>1662-5102</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkU1vEzEQhlcIRD_gzglZ4sJlgz_G9vqCFLU0RKoEonC27LU362hjF3vT0H_PJilVy8kjzzuP7Hmq6h3BM8Ya9amLrR9mFFM8w5hIeFGdEiFozQmmL5_UJ9VZKWuMBRXQvK5OGJUECMen1Y-5uzMTpaAQ0dh7dBNW0QwhrtB3M_Y7c1_QZdrFMmZvNih1aDEEM9Q3rclo_idFtMhpN_ZoGftgw5hyeVO96sxQ_NuH87z6dfXl58XX-vrbYnkxv65bUHisiZVUcUYocGaFJ7a1nuIGJFBqHEw94R0IAdxZJ6FRHRXEGug4EMEazs6r5ZHrklnr2xw2Jt_rZII-XKS80iaPoR28JkqBIgJAth04QmyDu8Z5KbAXoKScWJ-PrNut3XjX-jhmMzyDPu_E0OtVutOSgZCCTYCPD4Ccfm99GfUmlEnOYKJP26IpUMkpa6Saoh_-i67TNk9L36eI4sAx0CmFj6k2p1Ky7x4fQ7Dey9cH-XovXx_kTyPvn37iceCfbfYXV3-pTw</recordid><startdate>20200702</startdate><enddate>20200702</enddate><creator>Sami, Armin</creator><creator>Selzer, Michael E</creator><creator>Li, Shuxin</creator><general>Frontiers Research Foundation</general><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200702</creationdate><title>Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors</title><author>Sami, Armin ; Selzer, Michael E ; Li, Shuxin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antigens</topic><topic>axon regeneration</topic><topic>Cellular Neuroscience</topic><topic>Chondroitin sulfate</topic><topic>CSPG receptor</topic><topic>Heparan sulfate</topic><topic>Injuries</topic><topic>intracellular signaling</topic><topic>Intracellular signalling</topic><topic>Kinases</topic><topic>LAR</topic><topic>Mammals</topic><topic>Phosphatase</topic><topic>Proteins</topic><topic>Proteoglycans</topic><topic>PTPσ</topic><topic>Regeneration</topic><topic>scar inhibition</topic><topic>Signal transduction</topic><topic>Spinal cord</topic><topic>Spinal cord injuries</topic><topic>Traumatic brain injury</topic><topic>Tyrosine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sami, Armin</creatorcontrib><creatorcontrib>Selzer, Michael E</creatorcontrib><creatorcontrib>Li, Shuxin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cellular neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sami, Armin</au><au>Selzer, Michael E</au><au>Li, Shuxin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors</atitle><jtitle>Frontiers in cellular neuroscience</jtitle><addtitle>Front Cell Neurosci</addtitle><date>2020-07-02</date><risdate>2020</risdate><volume>14</volume><spage>174</spage><epage>174</epage><pages>174-174</pages><issn>1662-5102</issn><eissn>1662-5102</eissn><abstract>Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets for designing effective therapies for traumatic brain injury or spinal cord injury (SCI). CSPGs bind with high affinity to several transmembrane receptors, including two members of the leukocyte common antigen related (LAR) subfamily of receptor protein tyrosine phosphatases (RPTPs). Recent studies demonstrate that multiple intracellular signaling pathways downstream of these two RPTPs mediate the growth-inhibitory actions of CSPGs. A better understanding of these signaling pathways may facilitate development of new and effective therapies for CNS disorders characterized by axonal disconnections. This review will focus on recent advances in the downstream signaling pathways of scar-mediated inhibition and their potential as the molecular targets for CNS repair.</abstract><cop>Switzerland</cop><pub>Frontiers Research Foundation</pub><pmid>32714150</pmid><doi>10.3389/fncel.2020.00174</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1662-5102 |
ispartof | Frontiers in cellular neuroscience, 2020-07, Vol.14, p.174-174 |
issn | 1662-5102 1662-5102 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_1994916447cf4d11b80f8de760e64977 |
source | PubMed Central (Open Access); Publicly Available Content (ProQuest) |
subjects | Antigens axon regeneration Cellular Neuroscience Chondroitin sulfate CSPG receptor Heparan sulfate Injuries intracellular signaling Intracellular signalling Kinases LAR Mammals Phosphatase Proteins Proteoglycans PTPσ Regeneration scar inhibition Signal transduction Spinal cord Spinal cord injuries Traumatic brain injury Tyrosine |
title | Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T02%3A15%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advances%20in%20the%20Signaling%20Pathways%20Downstream%20of%20Glial-Scar%20Axon%20Growth%20Inhibitors&rft.jtitle=Frontiers%20in%20cellular%20neuroscience&rft.au=Sami,%20Armin&rft.date=2020-07-02&rft.volume=14&rft.spage=174&rft.epage=174&rft.pages=174-174&rft.issn=1662-5102&rft.eissn=1662-5102&rft_id=info:doi/10.3389/fncel.2020.00174&rft_dat=%3Cproquest_doaj_%3E2419545042%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2419545042&rft_id=info:pmid/32714150&rfr_iscdi=true |